Join
Live feed
·
PRReleasevia Quantisnow
Novartis AG logo

Novartis successfully completes acquisition of Avidity Biosciences, strengthening late-stage neuroscience pipeline and advancing xRNA strategy

ByQuantisnow·Wall Street's wire, on your screen.
NVS· Novartis AG
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NVS (Novartis AG) and more on Quantisnow.